Muna Bhanji Intellia Therapeutics, Inc. (NTLA) insider trading activity

NTLA Quotes by TradingView

Muna Bhanji is of Intellia Therapeutics, Inc.. Currently has a direct ownership of 19,468 shares of NTLA, which is worth approximately $200,909. The most recent transaction as insider was on Jan 29, 2025, when has been sold 265 shares (Common Stock) at a price of $9.97 per share, resulting in proceeds of $2,642. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.5K
1.34% 3M change
62.29% 12M change
Total Value Held $200,909

Muna Bhanji Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 29 2025
SELL
Open market or private sale
$2,642 $9.97 p/Share
265 Reduced 1.34%
19,468 Common Stock
Jun 12 2024
BUY
Grant, award, or other acquisition
-
7,737 Added 28.17%
19,733 Common Stock
Oct 31 2023
SELL
Open market or private sale
$6,333 $23.9 p/Share
265 Reduced 2.16%
11,996 Common Stock
Jul 31 2023
SELL
Open market or private sale
$11,217 $42.33 p/Share
265 Reduced 2.12%
12,261 Common Stock
Jul 06 2023
SELL
Open market or private sale
$73,373 $39.3 p/Share
1,867 Reduced 12.97%
12,526 Common Stock
Jun 14 2023
BUY
Grant, award, or other acquisition
-
4,425 Added 23.51%
14,393 Common Stock
Jun 14 2022
BUY
Grant, award, or other acquisition
-
2,014 Added 16.81%
9,968 Common Stock
Apr 28 2022
BUY
Grant, award, or other acquisition
-
7,954 Added 50.0%
7,954 Common Stock

Also insider at

CYTK
CYTOKINETICS INC Healthcare
Director
ARDX
ARDELYX, INC. Healthcare
Director
VCYT
VERACYTE, INC. Healthcare
Director
MB

Muna Bhanji

South San Francisco, CA

Track Institutional and Insider Activities on NTLA

Follow Intellia Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NTLA shares.

Notify only if

Insider Trading

Get notified when an Intellia Therapeutics, Inc. insider buys or sells NTLA shares.

Notify only if

News

Receive news related to Intellia Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NTLA